SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950157-09-000417
Filing Date
2009-07-15
Accepted
2009-07-14 19:26:12
Documents
7
Period of Report
2009-07-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8-k.htm 8-K 92365
2 AGREEMENT AND PLAN OF MERGER ex2-1.htm EX-2.1 659438
3 AMENDMENT NO. 2 TO RIGHTS AGREEMENT ex4-1.htm EX-4.1 33339
4 AMENDED AND RESTATED EMPLOYMENT AGREEMENT ex10-1.htm EX-10.1 202609
5 PRESS RELEASE ex99-1.htm EX-99.1 26729
6 PRESS RELEASE ex99-2.htm EX-99.2 14288
7 ex99-20.jpg GRAPHIC 16143
  Complete submission text file 0000950157-09-000417.txt   1052887
Mailing Address 11960 SW 144TH STREET MIAMI FL 33185
Business Address 11960 SW 144TH ST MIAMI FL 33186 3052535099
NOVEN PHARMACEUTICALS INC (Filer) CIK: 0000815838 (see all company filings)

IRS No.: 592767632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17254 | Film No.: 09944665
SIC: 2834 Pharmaceutical Preparations